Emerging nanoparticles for glioblastoma: Engineering precision across the blood-brain barrier
This review critically explore a diverse variety of advanced nanocarrier platforms designed for anti-proliferative, radiosensitizing and immunomodulatory interventions and highlights how rational nanoparticle design can shift GBM management toward targeted, multimodal precision therapy, offering renewed hope against one of oncology's most intractable diseases.